Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02117388 · ClinicalTrials.gov registry record · NA

Treatments for Insomnia: Mediators, Moderators and Quality of Life

A NA study of Insomnia, sponsored by Palo Alto Veterans Institute for Research.

Completed
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT02117388: Completed NA study of Insomnia, sponsored by Palo Alto Veterans Institute for Research.

NCT02117388 is a NA study of Insomnia that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 128 participants, below the 169-participant average among 151 other Insomnia trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02117388, a NA study of Insomnia, has completed, sponsored by Palo Alto Veterans Institute for Research.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the relative efficacy and effectiveness of specific components of cognitive behavioral therapies for insomnia: sleep restriction (SR) and cognitive therapy (CT) in comparison to combined SR and CT (SR+CT).

Primary Outcome

Subject's subjective evaluation of their sleep.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy
  • BEHAVIORAL Sleep Restriction
  • BEHAVIORAL Combined Therapy

Study Locations (1)

California

  • VA Palo Alto Health Care System - Palo Alto

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2013-09
Est. Completion 2019-08-23
Phase NA

What the finished NCT02117388 record still lists

NCT02117388 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 169-participant average among 151 other Insomnia trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT02117388 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02117388 about?

NCT02117388 is a clinical study titled "Treatments for Insomnia: Mediators, Moderators and Quality of Life". The purpose of this study is to evaluate the relative efficacy and effectiveness of specific components of cognitive behavioral therapies for insomnia: sleep restriction (SR) and cognitive therapy (CT) in comparison to combined SR and CT (SR+CT).

What is the current status of trial NCT02117388?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2013-09. Estimated completion is 2019-08-23.

What conditions does trial NCT02117388 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT02117388?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Sleep Restriction (BEHAVIORAL), Combined Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02117388?

This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02117388 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02117388's enrollment target sits among peer trials

128 54th of 151 higher than 98 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02117388, the US trial registry maintained by the National Library of Medicine. NCT02117388 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.